17:37 IST
BSE
Fund Raise
Bal Pharma Fund Raise
Bal Pharma will consider a proposal for fund raising through preferential warrants to promoters. The board meeting is scheduled for May 27, 2026.
Bal Pharma Ltd
- Share price
- ₹97.50
- Market cap
- ₹155.2 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 21.5×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Other Announcement 5Management Change 4Financial Results 3Capital Structure Change 3Dividend 2Board Meeting Date 2Price Movement Clarification 1Merger & Restructuring 1Legal & Regulatory 1Fund Raise 1Annual Report 1
Time
1 announcement with these filters